NUTX — Nutex Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapContrarian

Annual income statement for Nutex Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K/A	10-K	10-K/A	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	18.8	219	248	480	875
Cost of Revenue
Gross Profit	4.15	15.4	34.8	196	444
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	27.2	626	279	349	600
Operating Profit	-8.38	-407	-31.8	131	276
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-14.7	-420	-48.5	110	245
Provision for Income Taxes
Net Income After Taxes	-13.7	-433	-43.4	94.8	180
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-13.7	-425	-45.8	52.1	70.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-13.7	-425	-45.8	53.2	70.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-56.6	-38.6	-5.89	10.8	10.5